Spain· ES:1171193002
REFIXIA 1000 UI POLVO Y DISOLVENTE PARA SOLUCION INYECTABLE
A nonacog beta pegol product containing nonacog beta pegol, registered in Spain by Novo Nordisk A/S. The same ATC class is registered in 2 of our 19 countries.
Checked against AEMPS CIMA (Spain) on
Informational only — not a medical device.
Where it is registered
Nonacog beta pegol is registered in 2 of 19 countries.
Countries holding a registration under ATC B02BD36 (nonacog beta pegol), each read from that country’s own register.
- This record: Spain, from AEMPS CIMA (Spain)
- 1 of them publish a price we can compare per daily dose
Nonacog beta pegol · ATC B02BD36
2 / 19 countries
- Spainprice
- United Kingdom
The record
At a glance
AEMPS CIMA (Spain)- Active substance
- nonacog beta pegol
- Manufacturer
- Novo Nordisk A/S
- Country
- Spain (ES)
- ATC code
- B02BD36
- ATC class
- Nonacog beta pegol
- Defined daily dose
- 400 E, P
- Reimbursed
- Not published by this register
- Source register
- AEMPS CIMA (Spain)
- Last checked
- September 12, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Nonacog beta pegol in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- BelgiumRefixia 1000 IUNovo Nordisk
- NorwayRefixiaNovo Nordisk A/S
- SwedenRefixia 1000 IE Pulver och vätska till injektionsvätska, lösningNovo Nordisk A/S
- CanadaREBINYNNOVO NORDISK CANADA INC
- SwitzerlandRefixia 1000 IE, Pulver und Lösungsmittel zur Herstellung einer InjektionslösungNovo Nordisk Pharma AG
- CzechiaREFIXIANovo Nordisk A/S, Bagsvaerd
- United KingdomRefixia 1,000unit powder and solvent for solution for injection vialsNovo Nordisk Ltd
- IrelandRefixia 1 000 IU powder and solvent for solution for injectionNovo Nordisk A/S
Authorised across Europe · EMA
The same active substance is authorised in 2 EEA countries. Names it is sold under:
- Iceland · Refixia
- Norway · Refixia
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of AEMPS CIMA (Spain). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/3ce3d02e-47d3-49c7-99b8-eec736f437b2 GET /v1/drugs/3ce3d02e-47d3-49c7-99b8-eec736f437b2?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cpresc": "Uso Hospitalario",
"estado": "{\"aut\":1512946800000}",
"nregistro": "1171193002",
"substance": "nonacog beta pegol"
}See everything about nonacog beta pegol.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.